Crossmark

Tetrahydrocurcumin regulates the tumor immune microenvironment to inhibit breast cancer proliferation and metastasis via the CYP1A1/NF-κB signaling pathway

Crossref DOI link: https://doi.org/10.1186/s12935-023-02850-9

Published Online: 2023-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zeng, Anqi

Yu, Xinyue

Chen, Bao

Hao, Lu

Chen, Ping

Chen, Xue

Tian, Yuan

Zeng, Jing

Hua, Hua

Dai, Ying

Zhao, Junning
Funding

Funding for this research was provided by:

Fundamental Research Funds for Sichuan Provincial Scientific Research Institutes (A-2022N-Z-1)
License Information

Text and Data Mining valid from 2023-01-27

Version of Record valid from 2023-01-27
More Information

Article History

Received: 12 August 2022

Accepted: 6 January 2023

First Online: 27 January 2023

Declarations

:

: All animal experiments in this study have been approved by the Institutional Animal Care and Treatment Committee of Sichuan Academy of Traditional Chinese Medicine, and were conducted in accordance with ARRIVE guidelines.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below